The Mark Foundation provides grant support to an expanding network of scientists conducting research across cancer types. From individual investigators to multidisciplinary collaborative teams, our awardees represent the best scientific minds in cancer research and technological innovation and become a vital part of our scientific network. Since 2017, The Mark Foundation has awarded over $230 million in grants to investigators at more than 100 academic institutions across 16 countries.
The Mark Foundation employs various funding mechanisms, both independent and in collaboration with partner organizations. All grant submissions undergo rigorous peer review and are held to the strictest standards of scientific excellence.
You can browse our portfolio here.
ASPIRE Awards (Accelerating Scientific Platforms and Innovative Research) are designed to enable innovative approaches to solving high-impact problems in cancer research that tend to fall outside the scope of other funding opportunities.
Drug Discovery Partnership awards are designed to accelerate the trajectory of converting promising scientific discoveries into therapeutics that will benefit cancer patients.
Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.
Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer.
We invest in the next generation of cancer researchers through fellowships awards. Young talent is crucial to our quest for cures. We support two programs: Momentum Fellowships and Postdoctoral Fellowships.
The Mark Foundation Centers consist of dynamic teams of investigators who are pooling their capabilities, knowledge, and energies to transform how cancer is prevented, diagnosed, and treated.
Partnering with scientists to accelerate research that will transform the prevention, diagnosis, and treatment of cancer is at the core of what we do at The Mark Foundation. Since we launched in 2017, we’ve also formed unique collaborations with like-minded funding organizations to maximize our impact.